BCL2L2 Antikörper
Kurzübersicht für BCL2L2 Antikörper (ABIN6654583)
Target
Alle BCL2L2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Aufreinigung
- Purified
-
Reinheit
- Protein G affinity chromatography
-
Immunogen
- Full-length recombinant human protein was used as the immunogen for this Bcl2L2 antibody.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
-
The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the Bcl2L2 antibody to be titered up or down for optimal performance.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Immunohistochemistry (FFPE): 0.5-1 μg/mL for 30 min at RT,Prediluted IHC only format: incubate for 30 min at RT (1) -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the Bcl2L2 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
-
-
- BCL2L2 (BCL2-Like 2 (BCL2L2))
-
Andere Bezeichnung
- Bcl2L2 / Bcl-W
-
Hintergrund
- Bcl2L2, also called BCLW, promotes cell survival. Blocks dexamethasone-induced apoptosis. Mediates survival of postmitotic Sertoli cells by suppressing death-promoting activity of BAX.
Target
-